An entry point to the written heritage of the Middle Ages and the Renaissance in Western Europe, from the 8th to the 18th century.
A search engine of interoperable digitized manuscripts and rare books
Collaborative platform to manage and publish Biblissima authority data
Help for reading and learning classical languages, XML editing tools and environments
Expertise service around IIIF standards
Biblissima authority file: https://data.biblissima.fr/entity/Q281817
IIIF manifest
Full digitisation
Papier (filigranes var. Briquet 11727: Florence, 1438-1466), XVe s. (a. 1439), 40 ff. (f. 40 v° blanc), 293 x 218 mm.
Data Source: Persée - DER-IRHT, XXI
f. 1-1 v°: Vita Persii.
titre (add. du XVIe-XVIIe s.): «Comentum Persii nobilissimum ».
inc.: «Auctor iste nomine Persius natione tuscus genere clarissimus... ».
expl.: «...item coruo poetas et poetridas cantare nedas Pegaseum melos etc...» (texte remanié, cf. éd. O. Jahn, A. Persii Flacci Satirarum liber, Leipzig, 1843, p. 239-242).
f. 2-40: Ps. Cornvtvs ?, Commentarius in Persii Saturas.
pas de titre.
inc.: «Nec fonte etc... Ne requiritur istud enim nec requiritur d/ q/ d/ poete illi uel potando de Pegaseo fonte uel se soniando [sic] in Parnasso, se sapientiam dicunt acquisisse et se poetas esse... ».
expl.: «...acerui aceruose cumulationis in rugam tractum est a uestibus... PERSII EXPOSITIO FLACCI SATIRARVM MODVLANTIS CVM TIBIIS QVIA FLACCA GRECE TIBIA LATINE VEL FLACCVS A LOCO QVASI MODVLATOR QVASI FINEM CAPIT EXPLICIT AMEN ».
Origine: italienne, écriture humanistique cursive. Invocation du copiste qui date au f. 40: «... Deo gratias, amen 1439 » et qui dessine à la plume sur les deux tiers du feuillet une figure asymétrique à quatre cornes séparées par la mention en capitales: «COR / NV / TV / S» (cf. supra, Ross. 800, f. 64 v°).
Possesseurs: aucune indication.
Data Source: Biblissima
RDF exports to come…
You can view and manipulate this document directly on this site, compare it to others using the Mirador viewer, or drag and drop this icon into the IIIF viewer of your choice. Read more about IIIF